Header Logo

Connection

Wei Wang to Female

This is a "connection" page, showing publications Wei Wang has written about Female.
Connection Strength

0.350
  1. MDM2-NFAT1 dual inhibitor, MA242: Effective against hepatocellular carcinoma, independent of p53. Cancer Lett. 2019 09 10; 459:156-167.
    View in: PubMed
    Score: 0.087
  2. Discovery and Characterization of Dual Inhibitors of MDM2 and NFAT1 for Pancreatic Cancer Therapy. Cancer Res. 2018 10 01; 78(19):5656-5667.
    View in: PubMed
    Score: 0.083
  3. Stimulator Selection in SSVEP-Based Spatial Selective Attention Study. Comput Intell Neurosci. 2016; 2016:6410718.
    View in: PubMed
    Score: 0.073
  4. Design, synthesis and structure-activity relationship study of novel urea compounds as FGFR1 inhibitors to treat metastatic triple-negative breast cancer. Eur J Med Chem. 2021 Jan 01; 209:112866.
    View in: PubMed
    Score: 0.024
  5. Regenerative Metaplastic Clones in COPD Lung Drive Inflammation and Fibrosis. Cell. 2020 05 14; 181(4):848-864.e18.
    View in: PubMed
    Score: 0.023
  6. Biomechanical changes to Descemet's membrane precede endothelial cell loss in an early-onset murine model of Fuchs endothelial corneal dystrophy. Exp Eye Res. 2019 Mar; 180:18-22.
    View in: PubMed
    Score: 0.021
  7. Pharmacological activation of estrogen receptor beta augments innate immunity to suppress cancer metastasis. Proc Natl Acad Sci U S A. 2018 04 17; 115(16):E3673-E3681.
    View in: PubMed
    Score: 0.020
  8. Experimental Therapy of Advanced Breast Cancer: Targeting NFAT1-MDM2-p53 Pathway. Prog Mol Biol Transl Sci. 2017; 151:195-216.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.